Right sirmichael . . . and it will become the dominat drug in the $60 billion anti-inflammatory market because it works far better than any other anti-inflammatory and it has ZERO adverse side effects. This drug alone will make Ampio shares priceless beyond imagination. And then add in Optina, Zertane, Zertane ED, Vasaloc, ORP and NCE001. It's mind boggling and there is no other small cap company with a pipeline anywhere close to this one that is going to help so many people including investors.